-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Lm7Zxkax5tk45ZqsAY3TwUPkTdclBD7IMk8FFX2KrUYRH3pfBTP9XWaUsV7vyR4c q9c66wiww1EqzZG3aCxcdg== 0000217028-03-000004.txt : 20030924 0000217028-03-000004.hdr.sgml : 20030924 20030924151329 ACCESSION NUMBER: 0000217028-03-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030922 FILED AS OF DATE: 20030924 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AVENTIS INC CENTRAL INDEX KEY: 0000217028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21291 FILM NUMBER: 03907825 BUSINESS ADDRESS: STREET 1: 500 ARCOLA RD STREET 2: P O BOX 1200 M/S 5B14 CITY: COLLEGEVILLE STATE: PA ZIP: 19426-0107 BUSINESS PHONE: 6104548000 FORMER NAME: FORMER CONFORMED NAME: RHONE POULENC RORER INC DATE OF NAME CHANGE: 19920703 FORMER NAME: FORMER CONFORMED NAME: RORER GROUP INC DATE OF NAME CHANGE: 19900731 FORMER NAME: FORMER CONFORMED NAME: RORER AMCHEM INC DATE OF NAME CHANGE: 19770604 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTROGEN THERAPEUTICS INC CENTRAL INDEX KEY: 0001018710 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 742704230 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 CONGRESS AVE STREET 2: SUITE 1850 CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 5127089310 MAIL ADDRESS: STREET 1: 301 CONGRESS AVE STREET 2: SUITE 1850 CITY: AUSTIN STATE: TX ZIP: 78701 4 1 primary_doc.xml PRIMARY DOCUMENT X0201 4 2003-09-22 0 0001018710 INTROGEN THERAPEUTICS INC INGN 0000217028 AVENTIS INC 0 0 1 0 Common Stock 2003-09-22 4 S 0 33450 10.76 D 2736643 I 1 Common Stock 2003-09-23 4 S 0 34700 10.76 D 2701943 I 1 Owned directly by Aventis Holdings Inc. and beneficially owned by Aventis Inc. Note: On the Form 4 report filed by the Reporting Person on September 12, 2003, the number of shares of Issuer's Common Stock reported as beneficially following the transactions reported thereby was incorrectly reported as 3,860,293 as of September 10, 2003 instead of 3,820,293, and was incorrectly reported as 3,560,293 as of September 11, 2003 instead of 3,520,293. /s/ Gerald P. Belle, President 2003-09-24 EX-99 3 jfi.txt JOINT FILER INFORMATION Joint Filer Information Name: Aventis Holdings Inc. Address: 3711 Kennett Pike, Suite 200 Greenville, Delaware 19807 Designated Filer: Aventis Inc. Issuer: Introgen Therapeutics Inc. Nature of Interest: Direct (1) Date of Event Requiring Statement: September 22 and 23, 2004 Signature: /s/ Joseph M. Palladino -----END PRIVACY-ENHANCED MESSAGE-----